Want to continue viewing company data?

Sign up for exclusive competitive intelligence.
Company Data Subscription $329 per month (billed Annually)
Signup to View Free Sample

Qiagen NV (Qiagen) is a provider of molecular testing solutions. The company’s sample technologies help isolate and process DNA, RNA and proteins from samples such as blood, tissue and other materials; assay technologies to identify the genetic information of a pathogen in a tumor; bioinformatics solutions to analyze and interpret genomic data; and solutions to automate the use of consumables into efficient molecular testing workflows. It serves human healthcare, forensics, veterinary diagnostics, food safety testing, pharmaceutical and biotechnology and life sciences research markets. The company offers products directly and also through a network of independent distributors. It has operations in the Americas, Europe, the Middle East, Africa, and Asia-Pacific. Qiagen is headquartered in Venlo, the Netherlands.

Headquarters Netherlands

Address Hulsterweg 82, Venlo, 5912PL


Telephone 31 77 3556600

No of Employees 6,000

Industry Medical Equipment

Ticker Symbol & Exchange QIA (ETR)

Revenue (2021) $2.3B 20.4% (2021 vs 2020)

EPS XXX

Net Income (2021) XXX 42.7% (2021 vs 2020)

Market Cap* $10.0B

Net Profit Margin (2021) XXX 18.6% (2021 vs 2020)

* As of and is in US$

Explore premium data & analytics

120+

Medical Pipeline Products

A database of medical devices that are in the process to get approved for sale around the world. Devices that are in development, through to those in the approval process are included.

110+

Medical Marketed Products

A database of medical devices currently for sale around the world. Devices that have been approved by a regulatory authority are included.

80+

Medical Clinical Trials

A database of clinical trials planned, currently ongoing, completed, suspended, withdrawn, and terminated in countries around the world.

4

Clinical Trials

Determine Qiagen NV go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

1

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

Subscribe to Company Analytics & gain access to premium industry data & analytics Subscribe to Company Analytics & gain access to premium industry data & analytics Start Here

Products and Services

Products Services
Sample Technologies: Laboratory and Genomic Services
Primary Sample Technology Consumables
Secondary Sample Technology Consumables
XXX
XXX
XXX
Subscribe to Company Analytics for access to more products & services data Subscribe to Company Analytics for access to more products & services data Learn More

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2022 Contracts/Agreements In June, the company partnered with TCS in driving its cloud transformation strategy.
2022 New Products/Services In May, the company announced the launch of QIAstat-Dx Rise a high-capacity version of the QIAstat-Dx automated syndromic system.
2022 Contracts/Agreements In May, the company signed an agreement to acquire a 96% stake in BLIRT SA, a manufacturer of recombinant enzymes.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Get Started
Image for loader

Competitor Comparison

Key Parameters Qiagen NV Roche Diagnostics International Ltd Hologic Inc 4basebio AG Macherey-Nagel GmbH & Co KG
Headquarters Netherlands Switzerland United States of America Germany Germany
City Venlo Rotkreuz Marlborough Heidelberg Duren
State/Province - Zug Massachusetts - Nordrhein-Westfalen
No. of Employees 6,000 2,600 6,705 2 -
Entity Type Public Private Public Public Private
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more

Key Financial Charts

Operating Margin
Operating Margin
EPS (Earnings per Share)
EPS (Earnings per Share)
Debt to Equity Ratio
Debt to Equity Ratio
Return on Assets
Return on Assets
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Find out more
Executives
Name Position Board Since Age
Thierry Bernard Chief Executive Officer; Managing Director Senior Management 2020 57
Roland Sackers Managing Director; Chief Financial Officer Senior Management 2006 53
Lawrence A. Rosen Chairman Non Executive Board 2020 64
Stephany Foster Head - Human Resources; Senior Vice President Senior Management 2019 -
Dr. Jonathan Sheldon Senior Vice President - QIAGEN Digital Insights Business Area Senior Management 2018 -
Non Dignissim Eros Proin vel Convallis 2022 XX
Non Dignissim Eros Proin vel Convallis 2022 XX
Non Dignissim Eros Proin vel Convallis 2022 XX
Gain more insight into company management & employee structure with Company Analytics Gain more insight into company management & employee structure with Company Analytics Subscribe
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer